CI stock · EXOZ stock

CI vs EXOZ · P/E 2.4, rev $274.90B vs rev $70.1K

Cigna Corp (CI) versus eXoZymes, Inc. (EXOZ) — a side-by-side from cached financials, not a winner call.

Cigna Corp (CI) is a healthcare plans company listed on US.

eXoZymes, Inc. (EXOZ) is a biotechnology company listed on US.

Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.

Latest reported EXOZ revenue for 2023-12-31 was $70.1K. Net income was -$2.0M. Revenue was down 1.0% from 2023-09-30 to 2023-12-31. EXOZ currently screens at market cap $83.5M.

CI currently screens at market cap $71.62B and trailing P/E 2.4. EXOZ currently screens at market cap $83.5M.

Not investment advice. Open the CI and EXOZ stock pages for the full models.

Not investment advice.

Popular Stock Comparisons